BackLux Health Tech Acquisition - Warrants(30/11/2027) Overview
Lux Health Tech Acquisition Corp - Warrants(30/11/2027)

Lux Health Tech Acquisition - Warrants(30/11/2027) P/E Ratio

Latest P/E ratio for Lux Health Tech Acquisition - Warrants(30/11/2027): 7.85 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

7.85

P/E Ratio

7.85

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Lux Health Tech Acquisition - Warrants(30/11/2027) (LUXAW) FAQ

The latest P/E ratio for LUXAW is 7.85. That is below the sector sector average of 33.83. Investors often review this figure alongside Lux Health Tech Acquisition - Warrants(30/11/2027)'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, LUXAW currently prints 7.85 for P/E ratio, while the sector average sits near 33.83. That is roughly 76.8% below the sector mean. Large gaps often invite a closer look at Lux Health Tech Acquisition - Warrants(30/11/2027)'s growth, margins, and balance sheet.

A P/E ratio of 7.85 for Lux Health Tech Acquisition - Warrants(30/11/2027) is not 'good' or 'bad' on its own. Compare it with the peer average (33.83) and with LUXAW's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting LUXAW's P/E ratio (7.85), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.